Literature DB >> 8820266

IL-4 and IL-13 receptors: are they one and the same?

R E Callard1, D J Matthews, L Hibbert.   

Abstract

Interleukin 4 (IL-4) and IL-13 share several biological properties, suggesting that they also share a common receptor or receptor component. Indeed, as discussed here by Robin Callard and colleagues, the IL-13 receptor appears to be a functional receptor for IL-4.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8820266     DOI： 10.1016/0167-5699(96)80600-1

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


  28 in total

1.  Interleukin-4 (IL-4) and IL-13 signaling pathways do not regulate Borrelia burgdorferi-induced arthritis in mice: IgG1 is not required for host control of tissue spirochetes.

Authors:  M R Potter; N Noben-Trauth; J H Weis; C Teuscher; J J Weis
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 2.  Advances in the understanding of cytokine signal transduction: the role of Jaks and STATs in immunoregulation and the pathogenesis of immunodeficiency.

Authors:  J J O'Shea; L D Notarangelo; J A Johnston; F Candotti
Journal:  J Clin Immunol       Date:  1997-11       Impact factor: 8.317

3.  Thymic stromal lymphopoietin and the pathophysiology of atopic disease.

Authors:  Michael M Miazgowicz; Mark B Headley; Ryan P Larson; Steven F Ziegler
Journal:  Expert Rev Clin Immunol       Date:  2009-09-01       Impact factor: 4.473

4.  Interleukin-13 selectively induces monocyte chemoattractant protein-1 synthesis and secretion by human endothelial cells. Involvement of IL-4R alpha and Stat6 phosphorylation.

Authors:  M Goebeler; B Schnarr; A Toksoy; M Kunz; E B Bröcker; A Duschl; R Gillitzer
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

5.  Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAK1.

Authors:  S J Haque; Q Wu; W Kammer; K Friedrich; J M Smith; I M Kerr; G R Stark; B R Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

6.  Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4.

Authors:  F Q Cunha; S Poole; B B Lorenzetti; F H Veiga; S H Ferreira
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

Review 7.  Role of cytokines as a double-edged sword in sepsis.

Authors:  Hina Chaudhry; Juhua Zhou; Yin Zhong; Mir Mustafa Ali; Franklin McGuire; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  In Vivo       Date:  2013 Nov-Dec       Impact factor: 2.155

8.  Expression of interleukin-13 receptor alpha 1-subunit on peripheral blood eosinophils is regulated by cytokines.

Authors:  Daniel Myrtek; Mathias Knoll; Timm Matthiesen; Sebastian Krause; Jens Lohrmann; Dirk Schillinger; Marco Idzko; J Christian Virchow; Karlheinz Friedrich; Werner Luttmann
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

9.  IL-4 and IL-13 inhibit IL-1β and TNF-α induced kinin B1 and B2 receptors through a STAT6-dependent mechanism.

Authors:  P P C Souza; A B Brechter; R I Reis; C A S Costa; P Lundberg; U H Lerner
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

10.  Gene Therapy against Murine Melanoma B16F10-Nex2 Using IL-13Ralpha2-Fc Chimera and Interleukin 12 in Association with a Cyclopalladated Drug.

Authors:  Flavia Hebeler-Barbosa; Elaine G Rodrigues; Rosana Puccia; Antonio Cf Caires; Luiz R Travassos
Journal:  Transl Oncol       Date:  2008-09       Impact factor: 4.243
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.